Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Category list : Antirheumatic agents

Sort by: Newest first Oldest first A-Z Z-A

  • NICE approves another anti-TNF

    24 FEB 2010 16:25

    Certolizumab pegol (Cimzia) has been added to the tumour necrosis factor (TNF) inhibitors that can used to treat rheumatoid arthritis in the latest round of National Institute for Health and Clinical Excellence guidance, published this week.

  • Product news (13 February 2010)

    11 FEB 2010 7:05

    Accessing SPCsSPCs for medicines are available online

  • Rheumatoid arthritis: Management Subscription

    1 JAN 2010

    By Richard Copeland, MPhil, MRPharmS, and Carole Callaghan, MSc, MRPharmS

  • Clinical developments in 2009 Subscription

    1 JAN 2010 By Harriet Adcock


  • Rheumatoid arthritis patient

    Cancer risk not increased by anti-TNF therapy

    5 NOV 2009 16:11

    Cancer risk is not increased during the first six years after starting anti-tumour necrosis factor (anti-TNF) alpha treatment in patients with rheumatoid arthritis (RA), a new study indicates (Arthritis & Rheumatism 2009;60:3180).

  • Product news (17 October 2009)

    15 OCT 2009 10:38

    New medicinesCimziaComposition:Certolizumab pegol.Presentation:Solution for injection in prefilled syringe.Class:Tumour necrosis factor alpha inhibitor.

  • New drug for rheumatoid arthritis to be launched Subscription

    13 OCT 2009 13:50

    Certolizumab pegol (Cimzia), a pegylated antitumour necrosis factor drug for the treatment of moderate to severe active rheumatoid arthritis, will be available in the UK from 23 October 2009.

  • Early treatment with infliximab an option for RA

    7 SEP 2009 11:39

    Using tumour necrosis factor inhibitors for patients with recently diagnosed rheumatoid arthritis who have not responded to methotrexate has been given a boost with the publication of new data in The Lancet (2009;374:459).

  • Drug regimens for rheumatoid arthritis Subscription

    13 AUG 2009

    The goals of rheumatoid arthritis (RA) management are to relieve pain and inflammation, prevent joint destruction, preserve or improve functional ability, and maintain a patient’s normal lifestyle.

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.